Russell Frank Company’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $8.89M | Buy |
2,670,761
+178,980
| +7% | +$596K | 0.02% | 1017 |
|
|
2015
Q4 | $8.91M | Sell |
2,491,781
-19,726
| -0.8% | -$70.5K | 0.02% | 955 |
|
|
2015
Q3 | $12.6M | Buy |
2,511,507
+1,083,572
| +76% | +$5.45M | 0.02% | 762 |
|
|
2015
Q2 | $9.18M | Sell |
1,427,935
-462,352
| -24% | -$2.97M | 0.01% | 1050 |
|
|
2015
Q1 | $13.3M | Buy |
1,890,287
+134,707
| +8% | +$948K | 0.02% | 757 |
|
|
2014
Q4 | $13.5M | Sell |
1,755,580
-180,430
| -9% | -$1.39M | 0.02% | 758 |
|
|
2014
Q3 | $14.5M | Sell |
1,936,010
-207,841
| -10% | -$1.55M | 0.03% | 707 |
|
|
2014
Q2 | $20.8M | Buy |
2,143,851
+38,402
| +2% | +$372K | 0.04% | 548 |
|
|
2014
Q1 | $17.5M | Buy |
2,105,449
+52,410
| +3% | +$436K | 0.03% | 610 |
|
|
2013
Q4 | $18.7M | Sell |
2,053,039
-73,915
| -3% | -$672K | 0.03% | 565 |
|
|
2013
Q3 | $17M | Buy |
2,126,954
+37,899
| +2% | +$302K | 0.03% | 635 |
|
|
2013
Q2 | $16.1M | Buy |
+2,089,055
| New | +$16.1M | 0.03% | 619 |
|